China SXT Pharmaceuticals Inc (SXTC)
China SXT Pharmaceuticals Inc (NASDAQ-SXTC) is a Healthcare company whose common stock is listed on NASDAQ. The security context is common equity, so this overview refers to the company’s publicly traded shares rather than a fund, note, or other instrument. China SXT Pharmaceuticals Inc operates in the pharmaceuticals industry and is associated with traditional Chinese medicine products and related pharmaceutical activities in China. Its business profile is tied to the development, production, marketing, and sale of medicinal materials and prepared items used in that market. This summary is limited to the listed common stock and avoids broader claims about performance or operating scale.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SXTC
|
$1.59
|
-42.8% Downside
|
Overvalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
July 31, 2026
|
-12.6x
|
2.6x
|
68.8x
|
78.29 M
|
51.09 M
|
1.4%
|
99.2%
|
10.5
|
—
|
64.8%
|
